Skip to main content

Advertisement

SpringerLink
Log in

Guide to Enhanced Recovery for Cancer Patients Undergoing Surgery: ERAS for Patients Undergoing Cytoreductive Surgery with or Without HIPEC

  • Peritoneal Surface Malignancy
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

ERAS protocols may reduce length of stay and return to full functional recovery after cytoreductive surgery and HIPEC. Prehabilitation programs and post-operative goal directed pathways, along with other essential components of ERAS are discussed with supporting evidence.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Foster JM, Sleightholm R, Patel A, et al. Morbidity and mortality rates following cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy compared with other high-risk surgical oncology procedures. JAMA Netw Open. 2019;2(1):e186847. https://doi.org/10.1001/jamanetworkopen.2018.6847.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Spiliotis J, Halkia E, de Bree E. Treatment of peritoneal surface malignancies with hyperthermic intraperitoneal chemotherapy—current perspectives. Curr Oncol. 2016;23(3):e266–75. https://doi.org/10.3747/co.23.2831.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Ljungqvist O, Scott M, Fearon KC. Enhanced recovery after surgery a review. JAMA Surg. 2017;152(3):292–8. https://doi.org/10.1001/jamasurg.2016.4952.

    Article  PubMed  Google Scholar 

  4. Zhang X, Yang J, Chen X, Du L, Li K, Zhou Y. Enhanced recovery after surgery on multiple clinical outcomes: umbrella review of systematic reviews and meta-analyses. Medicine (Baltimore). 2020;99(29):e20983. https://doi.org/10.1097/MD.0000000000020983.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Nelson G, Kiyang LN, Crumley ET, et al. Implementation of enhanced recovery after surgery (ERAS) across a provincial healthcare system: the ERAS Alberta colorectal surgery experience. World J Surg. 2016;40(5):1092–103. https://doi.org/10.1007/s00268-016-3472-7.

    Article  PubMed  Google Scholar 

  6. Webb C, Day R, Velazco CS, et al. Implementation of an Enhanced Recovery After Surgery (ERAS) program is associated with improved outcomes in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. 2020;27(1):303–12. https://doi.org/10.1245/s10434-019-07900-z.

    Article  PubMed  Google Scholar 

  7. Lu PW, Fields AC, Shabat G, et al. Cytoreductive surgery and HIPEC in an enhanced recovery after surgery program: a feasibility study. J Surg Res. 2020;247:59–65. https://doi.org/10.1016/j.jss.2019.10.042.

    Article  PubMed  Google Scholar 

  8. Siddharthan R, Dewey E, Billingsley K, Gilbert E, Tsikitis VL. Feasibility and benefits of an enhanced recovery after surgery protocol for patients undergoing cytoreductive surgery and heated intraperitoneal chemotharpy: a single institution experience. Am J Surg. 2020;219(6):1073–5. https://doi.org/10.1016/j.amjsurg.2019.06.019.

    Article  PubMed  Google Scholar 

  9. Duzgun O. Evaluation of enhanced recovery after following a surgical protocol for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis. Med Arch (Sarajevo, Bosnia Herzegovina). 2019;73(5):331–7. https://doi.org/10.5455/medarh.2019.73.331-337.

    Article  PubMed Central  Google Scholar 

  10. Martin RC, Marshall BM, Philips P, Egger M, McMasters KM, Scoggins CR. Enhanced recovery after surgery is safe for cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. Am J Surg. 2020;220(6):1428–32. https://doi.org/10.1016/j.amjsurg.2020.08.041.

    Article  PubMed  Google Scholar 

  11. Maciver AH, Al-Sukhni E, Esquivel J, Skitzki JJ, Kane JM, Francescutti VA. Current Delivery of hyperthermic intraperitoneal chemotherapy with cytoreductive surgery (CS/HIPEC) and perioperative practices: an international survey of high-volume surgeons. Ann Surg Oncol. 2017;24(4):923–30. https://doi.org/10.1245/s10434-016-5692-3.

    Article  PubMed  Google Scholar 

  12. Eng OS, Blakely AM, Lafaro KJ, et al. Institutional variation in recovery after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: an opportunity for enhanced recovery pathways. J Surg Oncol. 2020;122(5):980–5. https://doi.org/10.1002/jso.26099.

    Article  PubMed  Google Scholar 

  13. Hübner M, Kusamura S, Villeneuve L, et al. Guidelines for perioperative care in cytoreductive surgery (CRS) with or without hyperthermic IntraPEritoneal chemotherapy (HIPEC): enhanced recovery after surgery (ERAS®) Society recommendations—part I: preoperative and intraoperative management. Eur J Surg Oncol. 2020;46(12):2292–310. https://doi.org/10.1016/j.ejso.2020.07.041.

    Article  PubMed  Google Scholar 

  14. Hübner M, Kusamura S, Villeneuve L, et al. Guidelines for perioperative care in cytoreductive surgery (CRS) with or without hyperthermic IntraPEritoneal chemotherapy (HIPEC): enhanced recovery after surgery (ERAS®) Society recommendations—part II: postoperative management and special considerati. Eur J Surg Oncol. 2020;46(12):2311–23. https://doi.org/10.1016/j.ejso.2020.08.006.

    Article  PubMed  Google Scholar 

  15. Abola RE, Bennett-Guerrero E, Kent ML, et al. American society for enhanced recovery and perioperative quality initiative joint consensus statement on patient-reported outcomes in an enhanced recovery pathway. Anesth Analg. 2018;126(6):1874–82. https://doi.org/10.1213/ANE.0000000000002758.

    Article  PubMed  Google Scholar 

  16. Aloia TA, Zimmitti G, Conrad C, Gottumukalla V, Kopetz S, Vauthey JN. Return to intended oncologic treatment (RIOT): a novel metric for evaluating the quality of oncosurgical therapy for malignancy. J Surg Oncol. 2014;110(2):107–14. https://doi.org/10.1002/jso.23626.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Biagi JJ, Raphael MJ, Mackillop WJ, Kong W, King WD, Booth CM. Association between time to initiation of adjuvant chemotherapy and survival in colorectal cancer a systematic review and meta-analysis. JAMA. 2011;305(22):2335–42. https://doi.org/10.1001/jama.2011.749.

    Article  CAS  PubMed  Google Scholar 

  18. Manso M, Schmelz J, Aloia T. ERAS—anticipated outcomes and realistic goals. J Surg Oncol. 2017;116(5):570–7. https://doi.org/10.1002/jso.24791.

    Article  PubMed  Google Scholar 

  19. Elias KM, Stone AB, McGinigle K, et al. The reporting on ERAS compliance, outcomes, and elements research (RECOvER) checklist: a joint statement by the ERAS® and ERAS® USA societies. World J Surg. 2019;43(1):1–8. https://doi.org/10.1007/s00268-018-4753-0.

    Article  PubMed  Google Scholar 

  20. Ni X, Jia D, Guo Y, Sun X, Suo J. The efficacy and safety of enhanced recovery after surgery (ERAS) program in laparoscopic digestive system surgery: a meta-analysis of randomized controlled trials. Int J Surg. 2019;69(July):108–15. https://doi.org/10.1016/j.ijsu.2019.07.034.

    Article  PubMed  Google Scholar 

  21. Luther A, Gabriel J, Watson RP, Francis NK. The impact of total body prehabilitation on post-operative outcomes after major abdominal surgery: a systematic review. World J Surg. 2018;42(9):2781–91. https://doi.org/10.1007/s00268-018-4569-y.

    Article  PubMed  Google Scholar 

  22. Cortés-Guiral D, Mohamed F, Glehen O, Passot G. Prehabilitation of patients undergoing cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal malignancy. Eur J Surg Oncol. 2020;47:60–4. https://doi.org/10.1016/j.ejso.2020.01.032.

    Article  PubMed  Google Scholar 

  23. Reece L, Dragicevich H, Lewis C, et al. Preoperative nutrition status and postoperative outcomes in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. 2019;26(8):2622–30. https://doi.org/10.1245/s10434-019-07415-7.

    Article  PubMed  Google Scholar 

  24. Arends J, Bachmann P, Baracos V, et al. ESPEN guidelines on nutrition in cancer patients. Clin Nutr. 2017;36(1):11–48. https://doi.org/10.1016/j.clnu.2016.07.015.

    Article  PubMed  Google Scholar 

  25. McClave SA, Taylor BE, Martindale RG, et al. Guidelines for the provision and assessment of nutrition support therapy in the adult critically ill patient: society of critical care medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (ASPEN). J Parenter Enter Nutr. 2016;40(2):159–211. https://doi.org/10.1177/0148607115621863.

    Article  CAS  Google Scholar 

  26. Achilli P, Mazzola M, Bertoglio CL, et al. Preoperative immunonutrition in frail patients with colorectal cancer: an intervention to improve postoperative outcomes. Int J Colorectal Dis. 2020;35(1):19–27. https://doi.org/10.1007/s00384-019-03438-4.

    Article  PubMed  Google Scholar 

  27. Moaven O, Votanopoulos KI, Shen P, et al. Health-related quality of life after cytoreductive surgery/HIPEC for mucinous appendiceal cancer: results of a multicenter randomized trial comparing oxaliplatin and mitomycin. Ann Surg Oncol. 2020;27(3):772–80. https://doi.org/10.1245/s10434-019-08064-6.

    Article  PubMed  Google Scholar 

  28. Alverdy JC, Hyman N. Bowel preparation under siege. Br J Surg. 2020;107(3):167–70. https://doi.org/10.1002/bjs.11454.

    Article  CAS  PubMed  Google Scholar 

  29. Sarin A, Chen LL, Wick EC. Enhanced recovery after surgery—preoperative fasting and glucose loading—a review. J Surg Oncol. 2017;116(5):578–82. https://doi.org/10.1002/jso.24810.

    Article  PubMed  Google Scholar 

  30. Rizvanović N, Nesek Adam V, Čaušević S, Dervišević S, Delibegović S. A randomised controlled study of preoperative oral carbohydrate loading versus fasting in patients undergoing colorectal surgery. Int J Colorectal Dis. 2019;34(9):1551–61. https://doi.org/10.1007/s00384-019-03349-4.

    Article  PubMed  Google Scholar 

  31. Verret M, Lauzier F, Zarychanski R, et al. Perioperative use of gabapentinoids for the management of postoperative acute pain: a systematic review and meta-analysis. Anesthesiology. 2020;133(2):265–79. https://doi.org/10.1097/ALN.0000000000003428.

    Article  PubMed  Google Scholar 

  32. Güldner A, Kiss T, Serpa Neto A, et al. Intraoperative protective mechanical ventilation for prevention of postoperative pulmonary complications. Anesthesiology. 2015;123(3):692–713. https://doi.org/10.1097/aln.0000000000000754.

    Article  PubMed  Google Scholar 

  33. Hedenstierna G. Small tidal volumes, positive end-expiratory pressure, and lung recruitment maneuvers during anesthesia: good or bad? Anesthesiology. 2015;123(3):501–3. https://doi.org/10.1097/ALN.0000000000000755.

    Article  PubMed  Google Scholar 

  34. Briel M, Meade M, Mercat A. Higher vs lower positive end-expiratory pressure in patients with acute lung injury. JAMA J Am Med Assoc. 2010;303(9):865–73.

    Article  CAS  Google Scholar 

  35. Eng OS, Dumitra S, O’Leary M, et al. Association of fluid administration with morbidity in cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. JAMA Surg. 2017;152(12):1156–60. https://doi.org/10.1001/jamasurg.2017.2865.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Colantonio L, Claroni C, Fabrizi L, et al. A randomized trial of goal directed vs standard fluid therapy in cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. J Gastrointest Surg. 2015;19(4):722–9. https://doi.org/10.1007/s11605-015-2743-1.

    Article  PubMed  Google Scholar 

  37. Pour-Ghaz I, Manolukas T, Foray N, et al. Accuracy of non-invasive and minimally invasive hemodynamic monitoring: where do we stand? Ann Transl Med. 2019;7(17):421–421. https://doi.org/10.21037/atm.2019.07.06.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Rottenstreich A, Kalish Y, Kleinstern G, Ben YA, Dux J, Nissan A. Factors associated with thromboembolic events following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Surg Oncol. 2017;116(7):914–20. https://doi.org/10.1002/jso.24746.

    Article  CAS  PubMed  Google Scholar 

  39. Vukadinovic V, Chiou JD, Morris DL. Clinical features of pulmonary emboli in patients following cytoreductive surgery (peritonectomy) and hyperthermic intraperitoneal chemotherapy (HIPEC), a single centre experience. Eur J Surg Oncol. 2015;41(5):702–6. https://doi.org/10.1016/j.ejso.2015.01.016.

    Article  CAS  PubMed  Google Scholar 

  40. McLeod RS, Aarts MA, Chung F, et al. Development of an enhanced recovery after surgery guideline and implementation strategy based on the knowledge-to-action cycle. Ann Surg. 2015;262(6):1016–25. https://doi.org/10.1097/SLA.0000000000001067.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, University of Chicago, 5841 S. Maryland Ave, MC 5094, Chicago, IL, 60637, USA

    Ankit Dhiman MBBS, MS, Emily Fenton BA, PA-C, Whitney Petersen BA, PA-C, Oliver S. Eng MD & Kiran Turaga MD, MPH

  2. University of Chicago Comprehensive Cancer Center, University of Chicago, Chicago, IL, USA

    Jeffrey Whitridge RD, Jennifer Belanski RN & Sarah Macaraeg PT

  3. Department of Anesthesiology, University of Chicago, Chicago, IL, USA

    Govind Rangrass MD

  4. Department of Medicine, University of Chicago, Chicago, IL, USA

    Ardaman Shergill MD & Dejan Micic MD

Authors
  1. Ankit Dhiman MBBS, MS
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Emily Fenton BA, PA-C
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jeffrey Whitridge RD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jennifer Belanski RN
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Whitney Petersen BA, PA-C
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Sarah Macaraeg PT
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Govind Rangrass MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Ardaman Shergill MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Dejan Micic MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Oliver S. Eng MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Kiran Turaga MD, MPH
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kiran Turaga MD, MPH.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 439 KB)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dhiman, A., Fenton, E., Whitridge, J. et al. Guide to Enhanced Recovery for Cancer Patients Undergoing Surgery: ERAS for Patients Undergoing Cytoreductive Surgery with or Without HIPEC. Ann Surg Oncol 28, 6955–6964 (2021). https://doi.org/10.1245/s10434-021-09973-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-021-09973-1

Search

Navigation